X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
21
PharmaCompass offers a list of Alprazolam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alprazolam manufacturer or Alprazolam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alprazolam manufacturer or Alprazolam supplier.
PharmaCompass also assists you with knowing the Alprazolam API Price utilized in the formulation of products. Alprazolam API Price is not always fixed or binding as the Alprazolam Price is obtained through a variety of data sources. The Alprazolam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Alpronax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alpronax, including repackagers and relabelers. The FDA regulates Alpronax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alpronax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alpronax manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alpronax supplier is an individual or a company that provides Alpronax active pharmaceutical ingredient (API) or Alpronax finished formulations upon request. The Alpronax suppliers may include Alpronax API manufacturers, exporters, distributors and traders.
click here to find a list of Alpronax suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alpronax DMF (Drug Master File) is a document detailing the whole manufacturing process of Alpronax active pharmaceutical ingredient (API) in detail. Different forms of Alpronax DMFs exist exist since differing nations have different regulations, such as Alpronax USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Alpronax DMF submitted to regulatory agencies in the US is known as a USDMF. Alpronax USDMF includes data on Alpronax's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alpronax USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Alpronax suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Alpronax Drug Master File in Japan (Alpronax JDMF) empowers Alpronax API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Alpronax JDMF during the approval evaluation for pharmaceutical products. At the time of Alpronax JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Alpronax suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Alpronax Drug Master File in Korea (Alpronax KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Alpronax. The MFDS reviews the Alpronax KDMF as part of the drug registration process and uses the information provided in the Alpronax KDMF to evaluate the safety and efficacy of the drug.
After submitting a Alpronax KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Alpronax API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Alpronax suppliers with KDMF on PharmaCompass.
A Alpronax CEP of the European Pharmacopoeia monograph is often referred to as a Alpronax Certificate of Suitability (COS). The purpose of a Alpronax CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Alpronax EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Alpronax to their clients by showing that a Alpronax CEP has been issued for it. The manufacturer submits a Alpronax CEP (COS) as part of the market authorization procedure, and it takes on the role of a Alpronax CEP holder for the record. Additionally, the data presented in the Alpronax CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Alpronax DMF.
A Alpronax CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Alpronax CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Alpronax suppliers with CEP (COS) on PharmaCompass.
A Alpronax written confirmation (Alpronax WC) is an official document issued by a regulatory agency to a Alpronax manufacturer, verifying that the manufacturing facility of a Alpronax active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Alpronax APIs or Alpronax finished pharmaceutical products to another nation, regulatory agencies frequently require a Alpronax WC (written confirmation) as part of the regulatory process.
click here to find a list of Alpronax suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Alpronax as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Alpronax API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Alpronax as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Alpronax and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Alpronax NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Alpronax suppliers with NDC on PharmaCompass.
Alpronax Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alpronax GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alpronax GMP manufacturer or Alpronax GMP API supplier for your needs.
A Alpronax CoA (Certificate of Analysis) is a formal document that attests to Alpronax's compliance with Alpronax specifications and serves as a tool for batch-level quality control.
Alpronax CoA mostly includes findings from lab analyses of a specific batch. For each Alpronax CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alpronax may be tested according to a variety of international standards, such as European Pharmacopoeia (Alpronax EP), Alpronax JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alpronax USP).
Market Place
